News EU cancer drugs rejection shows contrasts with FDA Europe’s expert medicines panel has rejected Puma Biotechnology’s breast
News Europe recommends Tecentriq in bladder cancer, but efficacy ... The European Union’s CHMP committee recommended 11 medicines on Friday, including five orphan drugs.
News PTC's muscular dystrophy drug can stay on EU market - regula... But PTC must conduct further trial to confirm Translarna's benefits.
News Lilly soft tissue cancer drug gets EU nod Regulators conditionally back Lartruvo, based on mid-stage data.
News Sandoz, Teva and Mylan generics to be suspended in EU Regulator concerned over data from contract research organisation.
News EU regulators back blood cancer stem cell therapy Molmed's treatment aims to prevent reduce risk of graft-versus-host disease.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
